SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on the FDAs upcoming decision on Capricors deramiocel for Duchenne muscular dystrophy, with traders citing the amended upper-limb data, rare-disease policy discussions and recent launch-related hiring as reasons for optimism. Others caution that approval is uncertain given the prior negative review and continuing questions about the evidence.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Precigens strong quarterly results and rapid PAPZIMEOS commercial uptake are driving attention, with traders highlighting the companys return to profitability and potential for further growth. The upbeat reaction is accompanied by short-squeeze speculation and interest in upcoming PRGN-2009 data and European expansion.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A run to a 52-week high has traders positioning around the expected Q3 earnings report, with BRIUMVIs sales growth supporting optimism. Buyout rumors and heavy short interest are fueling squeeze speculation, though some traders see earnings expectationsnot a confirmed acquisitionas the main driver.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCaths post-TDAPA Medicare add-on could fall sharply after Q1 2027 has fueled concerns about pricing and CorMedix revenue amid a steep selloff. Traders dispute whether DaVitas preliminary outlook signals a broader reimbursement decline, pointing to CMSs published estimate, while others criticize management for not clarifying the potential impact.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs Phase 3 REGAL leukemia trial reached its prespecified 80th death event, triggering final analysis and putting the GPS survival readout at the center of discussion. Traders are divided between optimism about a strong result and concerns about the control arm and trial design, while shares have come under pressure ahead of the binary catalyst.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is under pressure after a steep decline, with traders focused on analyst price-target cuts and uncertainty ahead of its earnings report, as well as concerns about digital-ad growth. Bulls argue the selloff is disconnected from the companys profitability and growth, while bears warn of more downside if results or guidance disappoint; some also point to broader tech-market weakness.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A sharp technology and AI-linked selloffintensified by Intels weak outlook and concerns about returns on heavy AI investmentis driving attention to QQQ. Traders are split between warning of more downside and treating the drop as an oversold dip with potential for a rebound.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

SMH is under pressure amid a semiconductor and tech selloff, as traders question whether heavy AI infrastructure spending will generate adequate returns; weak Intel guidance and concerns about Amazons elevated capex are cited as contributing pressures. The community is divided between expecting a deeper unwind in the AI trade and seeing oversold conditions and technical support as possible grounds for a bounce.

Okta, Inc. engages in the provision of an identity management platform for enterprises. The firm operates through the following geographical segments: United States and International. Its products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Oktas strong quarterly results and raised outlook, alongside expectations that AI agents will increase demand for identity security, fueled a sharp rally. Traders are now debating whether the growth outlook justifies the valuation, with some taking profits or positioning for a pullback.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons stronger-than-expected third-quarter results, supported by growth in Eylea HD and Sanofi collaboration revenue from Dupixent, drove a sharp share-price gain. Traders largely celebrated the earnings beat and breakout, while some pointed to the upcoming cemdisiran decision as another potential catalyst.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gates Industrial (GTES) Q3 Earnings Top Estimates

Gates Industrial (GTES) delivered earnings and revenue surprises of +4.44% and -0.03%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Illinois Tool Works (ITW) Surpasses Q3 Earnings Estimates

Illinois Tool Works (ITW) delivered earnings and revenue surprises of +0.33% and -0.59%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Xometry CEO Sells 1,500 Shares Amid a 67% One-Year Return

Key PointsThe disposal involved 1,500 shares executed at a weighted average price of $85.23, representing a total transaction value of $127,845 on September 14, 2026...

Top 3D Printing Stocks to Buy for Solid Long-Term Returns

3D Printing is reshaping industries with faster production and lower costs, drawing investor interest. Stocks like ATI, NVDA, AVNT, PRLB and SNPS offer strong growth potential.

Xometry Director Sells 10,000 Shares

Key PointsThe transaction was valued at approximately $947,700...

Here's Why Xometry (XMTR) Could be Great Choice for a Bottom Fisher

After losing some value lately, a hammer chart pattern has been formed for Xometry (XMTR), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

JPMorgan's Top Consumer Tech Picks: 5 Stocks It Likes Right Now

JPMorgan highlights five favorite consumer tech stocks: Shopify, Take-Two, Clear, Xometry and EverQuote, citing AI and long-term growth.read more...

All You Need to Know About Xometry (XMTR) Rating Upgrade to Buy

Xometry (XMTR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Top 3D Printing Stocks to Buy for Strong Long-Term Potential

3D Printing is reshaping industries with faster production and lower costs, drawing investor interest. Stocks like PRLB, SSYS, AME, ATRI and CRS offer strong growth potential.

Xometry (XMTR) Beats Q2 Earnings and Revenue Estimates

Xometry (XMTR) delivered earnings and revenue surprises of +33.33% and +6.38%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Xometry, Inc. offers an AI-powered marketplace, the popular Thomasnet industrial sourcing platform, and a suite of cloud-based services. Xometry's marketplaces use proprietary AI to help buyers efficiently source custom-manufactured parts and assemblies and attain instant pricing and lead times. The AI enables a rapidly growing network of manufacturers to select the optimal jobs to fill capacity. The firm's suite of cloud-based services and Thomasnet industrial sourcing platform help manufacturers and industrial service providers grow businesses using advertising, marketing, and financial services. It operates through the following geographical segments: the United States and International. The company was founded by Laurence Zuriff and Randolph Altschuler in 2013 and is headquartered in North Bethesda, MD.

Xometry Inc - Ordinary Shares - Class A

GOOGL, UBER, RDDT, XMTR Stocks Top Wedbush's Internet Picks – AI Called 'Single Most Impactful Swing Factor'

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>Alphabet received Wedbush's highest-conviction mega-cap rating, with a $445 price target implying roughly 20% upside from Wednesday's close.</li><li>The firm’s price targets for Uber, Reddit, and Xometry each carried an implied upside of more than 25%.</li><li>Amazon and Instacart also earned 'Outperform' ratings, while Meta, DoorDash, and Pinterest were initiated with 'Neutral' ratings, reflecting more limited upside potential.</li></ul>Wedbush on Thursday named Alphabet (GOOGL), Uber (UBER), Reddit (RDDT), and Xometry (XMTR) its top internet stock picks across different market-cap categories, with analyst Ygal Arounian calling artificial intelligence (AI) the "single most impactful swing factor" shaping the sector's outlook.The firm stated that the companies with the “strongest combination of technology, product, and distribution” are best positioned to benefit as AI reshapes the internet industry.&nbsp;Wedbush's preferred names outperformed in pre-market trade, given that the Nasdaq-100 tracking&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust</a> (QQQ) fell 0.83% in premarket trading, while the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY) slipped 0.26%.<a href="https://stocktwits.com/symbol/GOOGL">GOOGL’s stock</a> and&nbsp;<a href="https://stocktwits.com/symbol/UBER">UBER shares</a> rose nearly 1% each.&nbsp;<a href="https://stocktwits.com/symbol/RDDT">RDDT stock</a> edged 0.25% higher, while&nbsp;<a href="https://stocktwits.com/symbol/XMTR">XMTR shares</a> traded flat.&nbsp;<h2 class="st-heading-2">The Big Three: Alphabet, Amazon, Meta</h2>Among the mega-cap internet names, Wedbush named Alphabet its top pick with an ‘Outperform' rating and a $445 price target, implying a potential 20% upside from Wednesday's close of around $370.Retail sentiment on Stockwits around GOOGL’s stock rose to ‘bullish’ from ‘bearish’ territory over the past day, accompanied by chatter at ‘normal’ levels. &nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_07_16_082327_png_7d39d455f3.webp" alt="Screenshot 2026-07-16 082327.png" width="1276" height="688"><figcaption>GOOGL stock retail sentiment on July 16 as of 8:15 a.m. ET | Source: Stocktwits&nbsp;</figcaption></figure>Amazon (AMZN) shares also received an ‘Outperform’ rating with a $293 price target, representing about 15% potential upside from a $254 closing price in the previous session.&nbsp;Meta Platforms (META) was the only mega-cap to receive a ‘Neutral’ rating. While Wedbush assigned a $671 price target, that sits below Wednesday's closing price of $681, implying limited near-term upside after the stock's strong rally.<a href="https://stocktwits.com/symbol/AMZN">AMZN’s stock</a> moved 0.6% higher in pre-market trade, while&nbsp;<a href="https://stocktwits.com/symbol/META">META’s stock</a> edged 0.14% higher. On Stockwits, retail sentiment around META remained in ‘bullish’ territory over the past day, while sentiment around AMZN improved to ‘bullish’ from the ‘neutral’ zone.<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_07_16_082433_png_a20f13c373.webp" alt="Screenshot 2026-07-16 082433.png" width="1280" height="696"><figcaption>AMZN stock retail sentiment on July 16 as of 8:15 a.m. ET | Source: Stocktwits&nbsp;</figcaption></figure><h2 class="st-heading-2">Uber, Reddit, Xometry Lead Across Their Categories</h2>Wedbush selected Uber as its preferred large-cap internet stock, assigning an ‘Outperform’ rating and a $91 price target, implying approximately 27% upside from Wednesday's close of around $72.Instacart (CART) also earned an ‘Outperform’ rating with a $59 target, representing roughly 24% upside from Wednesday’s close of around $47. By comparison, DoorDash (DASH) received a ‘Neutral’ rating despite a $205 price target, leaving only about 8% upside from Wednesday's close of $190.&nbsp;<a href="https://stocktwits.com/symbol/DASH">DASH’s stock</a> edged 0.4% higher in pre-market trade, while&nbsp;<a href="https://stocktwits.com/symbol/CART">CART’s stock</a> traded flat.Retail sentiment around UBER and DASH on Stocktwits trended in ‘bearish’ territory over the past day, while sentiment around CART fell to ‘neutral’ from the ‘bullish’ zone.<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_07_16_082611_png_6267e409af.webp" alt="Screenshot 2026-07-16 082611.png" width="1256" height="690"><figcaption>CART stock retail sentiment on July 16 as of 8:20 a.m. ET | Source: Stocktwits&nbsp;</figcaption></figure>Among social platforms, Reddit was Wedbush's top mid-cap pick. The firm assigned an ‘Outperform’ rating and a $250 target, implying about 26% upside from a closing price of $198 in the previous session. Pinterest, meanwhile, received a ‘Neutral’ rating with a $24 price target, reflecting far more modest expected gains than Reddit.For small-cap internet stocks, Wedbush named Xometry its preferred pick, initiating coverage with an ‘Outperform’ rating and a $126 price target, implying nearly 28% upside.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/atai-stock-soars-on-eli-lilly-s-2-8-b-buyout-why-cmps-shares-rising-too/cZZEJ7vR7sI">ATAI Stock Soars On Eli Lilly’s $2.8B Buyout – Why Are CMPS Shares Rising Too?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

A Google logo is displayed outside an office building on December 12, 2025 in San Diego, CA. (Photo by Kevin Carter/Getty Images)

Wedbush on Thursday named Alphabet (GOOGL), Uber (UBER), Reddit (RDDT), and Xometry (XMTR) its top internet stock picks across different market-cap categories, with analyst Ygal Arounian calling artificial intelligence (AI)

 Which Internet Stocks Could Benefit Most From AI? Wedbush Has Four Favorites

The Wall Street firm stated that companies with the strongest technology, products, and distribution are best positioned to benefit.


Alphabet Inc - Ordinary Shares - Class C

Alphabet Inc Class A

Reddit Inc

Uber Technologies Inc

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

XMTR News